Roche has 60.4% of Spark, plans to wrap up takeover on Tuesday
December 17, 2019 at 01:22 AM EST
Swiss drugmaker Roche Holding plans to complete on Tuesday its $4.3 billion takeover of Spark Therapeutics, it said, after winning U.S. regulatory approval for the long-delayed deal.
